CervoMed Inc. Files 8-K: Regulation FD & Financials
Ticker: CRVO · Form: 8-K · Filed: Aug 5, 2025 · CIK: 1053691
| Field | Detail |
|---|---|
| Company | Cervomed Inc. (CRVO) |
| Form Type | 8-K |
| Filed Date | Aug 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, financial-statements, corporate-filing
TL;DR
CervoMed filed an 8-K on Aug 5th covering Reg FD and financials. Check it out.
AI Summary
CervoMed Inc. filed an 8-K on August 5, 2025, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Diffusion Pharmaceuticals Inc., is incorporated in Delaware and headquartered in Boston, Massachusetts.
Why It Matters
This filing provides updates on regulatory disclosures and financial statements, which are crucial for investors to assess the company's current standing and compliance.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial statements and regulatory information, not indicating any immediate operational or financial distress.
Key Numbers
- 001-37942 — Commission File Number (Identifies the company's SEC filing history.)
- 30-0645032 — I.R.S. Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- CervoMed Inc. (company) — Registrant
- Diffusion Pharmaceuticals Inc. (company) — Former company name
- August 5, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Boston, Massachusetts (location) — Principal executive offices
FAQ
What specific events or information are being disclosed under Regulation FD?
The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in this excerpt.
What financial statements are included in this filing?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific statements are not detailed in this excerpt.
When was CervoMed Inc. formerly known as Diffusion Pharmaceuticals Inc.?
The date of the name change from Diffusion Pharmaceuticals Inc. to CervoMed Inc. is not specified in this excerpt, only that it is a former name.
What is the principal business of CervoMed Inc.?
CervoMed Inc. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]' according to its Standard Industrial Classification.
Where are CervoMed Inc.'s principal executive offices located?
CervoMed Inc.'s principal executive offices are located at 20 Park Plaza, Suite 424, Boston, Massachusetts 02116.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 5, 2025 regarding CervoMed Inc. (CRVO).